WeVote
Log In

Bill

Bill

A 1439

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer and requires certain health care providers offer annual testing for ovarian cancer

2025 Regular Session Introduced by Jeffrey Dinowitz and 5 co-sponsors

Bill A 1439 mandates full insurance coverage for annual ovarian cancer testing, ensuring women access vital screenings without financial barriers, improving early detection.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 1439

Summary of Bill A 1439

Bill Overview

  • Bill Number: A 1439
  • Title: Requires health insurance policies to offer full coverage for annual testing for ovarian cancer and requires certain health care providers to offer annual testing for ovarian cancer.
  • Status: Referred to Insurance Committee
  • Introduced On: January 09, 2025
  • Classification: Legislative Bill

Purpose and Intent

The primary purpose of Bill A 1439 is to enhance the early detection of ovarian cancer by mandating that health insurance policies provide full coverage for annual testing. This bill aims to ensure that women have access to necessary screenings without financial barriers, thereby promoting early diagnosis and potentially improving health outcomes.

Key Provisions

  • Insurance Coverage Requirement:

    • The bill mandates that all health insurance policies must cover the costs associated with annual ovarian cancer testing. This includes any necessary procedures, consultations, and follow-up care related to the testing.

  • Provider Obligations:

    • Certain healthcare providers will be required to offer annual ovarian cancer testing to eligible patients. This provision ensures that women have access to testing in a timely manner and that healthcare providers are equipped to facilitate these screenings.

Impact

  • Who Will Be Affected:
    • Women: The primary beneficiaries of this bill are women, particularly those at higher risk for ovarian cancer. By ensuring full coverage for testing, the bill aims to reduce the financial burden associated with these essential health services.
    • Healthcare Providers: Providers who are mandated to offer testing will need to adapt their practices to comply with the new requirements, which may involve training and resource allocation.
    • Insurance Companies: Health insurers will need to adjust their policies to include the mandated coverage, which could impact their pricing structures and overall healthcare plans.

Procedural Aspects

  • Current Status: As of January 9, 2025, the bill has been referred to the Insurance Committee for further consideration. The next steps will involve discussions, potential amendments, and voting within the committee before it can proceed to the full legislative body.

Related Legislation

  • Prior Session Bills:
    • A 9228
    • A 1641
  • Companion Bill:
    • S 1282 (introduced in the Senate)

This summary provides an overview of Bill A 1439, highlighting its intent, key provisions, and potential impacts on women’s health and the healthcare system. As the bill progresses through the legislative process, further developments will be monitored to assess its implications.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.